期刊文献+

3.0T MRI流入反转恢复序列在门静脉非对比增强成像中的应用 被引量:6

Application of inflow inversion recovery sequence in non-enhanced 3.0 T MR portal venography
下载PDF
导出
摘要 目的探讨3.0 T MR流入反转恢复(IFIR)序列对门静脉系统进行非对比增强成像的可行性。方法 60例疑诊上腹部病变患者行3.0 T MRI门静脉冠状位IFIR序列扫描及肝脏快速容积采集(LAVA)技术增强扫描,将扫描图像在工作站行三维MIP重建,由两名有经验的影像诊断医生分析两种方法对门静脉及其分支的显示,并进行评分,比较两者对门静脉显示的差异。结果 60例IFIR序列均能显示门静脉主干及肝内1、2级分支,其中门静脉成像评分5分16例,4分20例,3分21例,2分3例;60例LAVA序列均能显示门静脉主干及肝内1级分支,其中门静脉成像评分5分14例,4分24例,3分18例,2分3例,1分1例,两种方法门静脉成像评分的差异无统计学意义(P>0.05)。结论 3.0 T MRI IFIR成像序列能在不用对比剂情况下获得与增强MRA相似成像效果的门静脉系统图像。 Objective To evaluate the feasibility of inflow inversion recovery sequence in non-enhanced 3.0 T MR portal venography. Methods Portal vein imaging with the inflow inversion recovery(IFIR) sequence and with the liver acquisition volume acceleration(LAVA) sequence was performed on 60 patients with suspected abdominal disease using 3.0 T MRI. MIP reconstructed images of both sequences were scored from 1 to 5 by two experienced radiologists to compare the image quality of the branches and trunk of the portal vein. Results The IFIR sequence showed the first and second portal vein branches in all 60 patients with highest image quality score of 5 in 16, score 4 in 20, score 3 in 21, score 2 in 3. The LAVA sequence showed the first branches in all 60 patients with score of 5 in 14, score 4 in 24, score 3 in 18, score 2 in 3, score 1 in 1. There was no significant difference between the scores of the two sequences(P〉0.05). Conclusion IFIR sequence is a feasible non-enhanced MR imaging method with imaging quality of the portal vein similar to the contrast-enhanced MRA at 3.0 T MRI.
出处 《影像诊断与介入放射学》 2015年第3期195-198,共4页 Diagnostic Imaging & Interventional Radiology
关键词 流入反转恢复 磁共振血管造影术 门静脉成像 Inflow inversion recovery Magnetic resonance angiography Portal venography
  • 相关文献

参考文献16

  • 1Buhaeseu I, Izzedine H. Gadolinium-induced nephmtoxieity. Int J Clin Praet, 2008,62:1113-1118.
  • 2Laissy JP, Trillaud H, Douek P. MR angiography : noninvasive vascular imaging of the abdomen. Abdom Imaging, 2002,27: 488-506.
  • 3武靖,刘伟,杜湘珂,李毅,吴巍珍,王正.3.0T MR流入反转恢复序列门静脉成像及影响成像质量的技术因素[J].中国医学影像技术,2013,29(6):1011-1014. 被引量:8
  • 4Shiragami K, Fujii Z, Sakumura T, et al. Effect of a contrast agent on long-term renal function and the efficacy of prophylactic hemodiafiltration. Circ J, 2008,72 : 427-433.
  • 5郑兰,曹惠霞.非增强磁共振肾动脉成像技术的研究及临床应用[J].中国医学影像技术,2010,26(10):2002-2004. 被引量:1
  • 6Potthast S, Maki JH. Non-contrast-enhanced MR imaging of the renal arteries. Magn Reson Imaging Clin N Am, 2008,16 : 573-584.
  • 7Huot SJ, Hanssan JH, De), H, et al. Utility of captopril renal scans for detecting renal artery stenosis. Arch Intern Med, 2002, 162:1981-1984.
  • 8Grebner T. Gadotinium-a specific trigger for the development of nephrogenic fibresing dermopathy and nephrogenic systemic fibrosis? Nephrel Dial Transplant, 2006,21 : 1104-1108.
  • 9何必立,吕宾,许茂盛.磁共振门静脉造影术对门静脉系统的研究价值[J].世界华人消化杂志,2002,10(10):1210-1212. 被引量:4
  • 10Wilson GJ, Maki JH. Non-contrast-enhanced MR imaging of renal artery stenosis at 1.5 tesla. Magn Reson Imaging Clin N Am, 2009,17 : 13-27.

二级参考文献84

  • 1冯敏,顾建平,王书智,毛存南.MRA在诊断外周血管疾病中的价值:与DSA对照研究[J].临床放射学杂志,2005,24(9):811-813. 被引量:12
  • 2刘崎,陆建平,王飞,王莉,田建明,金爱国,汪剑.三维增强MR血管造影在主动脉夹层诊断中的价值[J].中华放射学杂志,2005,39(12):1260-1264. 被引量:42
  • 3林江,陈财忠,王建华,严福华,曾蒙苏,周康荣.肾动脉狭窄的三维增强磁共振血管成像诊断[J].放射学实践,2006,21(8):791-793. 被引量:4
  • 4陈祖望,周康荣,王建华,颜志平,杨培强,沈继章,陈财忠,施伟斌.TIPS术前门静脉MRA评价初探[J].中国医学计算机成像杂志,1996,2(4):243-245. 被引量:5
  • 5Vasbinder GB, Nelemans PJ, Kessels AG, et al. Diagnostic Tests for Renal Artery Stenosis in Patients Suspected of Having Renovascular Hypertension: A Meta-analysis[J]. Ann Intern Med, 2001,135(6) :401-411.
  • 6Fain SB, King BF, Breen JF, et al. High-Spatial-Resolution Contrast enhanced MR Angiography of the Renal Arteries: A Prospective Comparison with Digital Subtraction Angiography[J]. Radiology, 2001,218 (2) :481-490.
  • 7Schoenberg SO, Rieger J, Weber CH, et al. High-Spatial-Resolution MR Angiography of Renal Arteries with Integrated Parallel Acquisitions: Comparison with Digital Subtraction Angiography and US[J]. Radiology, 2005,235 (2) : 687-698.
  • 8Shiragami K, Fujii Z, Sakumura T, et al. Effect of a Contrast Agent on Long-term Renal Function and the Efficacy of Prophylactic Hemodiafiltration[J].Circ J, 2008,72 (3) :427-433.
  • 9Marckmann P,Skov L,Rossen K, et al. Nephrogenic Systemic Fibrosis:Suspected Causative Role of Gadodiamide Used for Con trast enhanced Magnetic Resonance Imaging[J]. J Am Soc Neph rol,2006,17(9) :2359- 2362.
  • 10Mendoza FA,Artlett CM,Sandorfi N, et al. Description of 12 Cases of Nephrogenic Fibrosing Dermopathy and Review of the Literature[J]. Semin Arthritis Rheum, 2006,35 (4) : 238-249.

共引文献35

同被引文献34

引证文献6

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部